Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction

BACKGROUND: Inflammation and oxidative stress have been implicated in the pathogenesis of atrial fibrillation (AF). Lipid-lowering drugs, particularly statins and fibrates, possess anti-inflammatory and antioxidant properties. OBJECTIVES: The purpose of this study was to assess the impact of lipid-l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hanna, Ibrahim R., Heeke, Brent, Bush, Heather, Brosius, Lynne, King-Hageman, Diane, Dudley, Samuel C., Beshai, John F., Langberg, Jonathan J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2006
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3164215/
https://ncbi.nlm.nih.gov/pubmed/16876733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hrthm.2006.05.010
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak